Japan Tissue EngineeringJapan Tissue Engineering Co., Ltd.7774東証グロース精密機器FY ending Mar 2026, non-consolidated, J-GAAP

Japan Tissue Engineering revenue and profit

It lost about ¥25 for every ¥100 of sales at the operating level. Revenue changed -11.1% from the prior year.

Five-year trend

Revenue¥2.18B
FY ending Mar 2022: ¥2.1B¥2.1BFY ending Mar 2023: ¥2.03B¥2.03BFY ending Mar 2024: ¥2.51B¥2.51BFY ending Mar 2025: ¥2.46B¥2.46BFY ending Mar 2026: ¥2.18B¥2.18BFY22FY23FY24FY25FY26
Operating income-¥549.4M
FY ending Mar 2022: -¥498.2M-¥498.2MFY ending Mar 2023: -¥728.1M-¥728.1MFY ending Mar 2024: ¥144.5M¥144.5MFY ending Mar 2025: -¥238.3M-¥238.3MFY ending Mar 2026: -¥549.4M-¥549.4MFY22FY23FY24FY25FY26
Operating margin-25.2%
FY ending Mar 2022: -23.7%-23.7%FY ending Mar 2023: -35.8%-35.8%FY ending Mar 2024: 5.7%5.7%FY ending Mar 2025: -9.7%-9.7%FY ending Mar 2026: -25.2%-25.2%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin—
2024: 5.7%5.7%2223242526
Asset turnover—
2024: 0.36×0.36×2223242526
ROA-12.0%
2022: -6.6%-6.6%2023: -10.1%-10.1%2024: 2.1%2.1%2025: -3.8%-3.8%2026: -12.0%-12.0%2223242526
Financial leverage—
2024: 1.15×1.15×2223242526
ROE—
2024: 2.4%2.4%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
2022——×-6.6%—×—
2023——×-10.1%—×—
20245.7%0.36×2.1%1.15×2.4%
2025——×-3.8%—×—
2026——×-12.0%—×—

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue61.2%
2021: 68.9%68.9%2022: 76.7%76.7%2023: 77.1%77.1%2024: 60.1%60.1%2025: 57.8%57.8%2026: 61.2%61.2%212223242526
PPE ÷ total assets23.5%
2021: 19.2%19.2%2022: 21.2%21.2%2023: 22.8%22.8%2024: 21.6%21.6%2025: 21.8%21.8%2026: 23.5%23.5%212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥497.3M
2021: ¥468.9M¥468.9M2022: ¥561.9M¥561.9M2023: ¥573.3M¥573.3M2024: ¥407M¥407M2025: ¥506.7M¥506.7M2026: ¥497.3M¥497.3M212223242526
R&D / revenue22.8%
2021: 20.8%20.8%2022: 26.7%26.7%2023: 28.2%28.2%2024: 16.2%16.2%2025: 20.6%20.6%2026: 22.8%22.8%212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue2,1032,0322,5142,4552,183
Cost of revenue848896824944915
Gross profit1,2551,1371,6911,5111,267
SG&A1,7541,8651,5461,7501,817
Operating income-498-728145-238-549
Pretax income-494-725147-234-731
Income tax444214
Net income attributable to owners-498-729143-255-735
Operating margin-23.7%-35.8%5.7%-9.7%-25.2%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 25%
Property, plant and equipment 24%
1%
2%
Other assets 48%

Funding

Other liabilities 10%
Equity 90%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥1.53B¥2.03B¥2.07B¥1.69B¥1.45B
Total assets¥7.6B¥6.88B¥6.99B¥6.51B¥5.68B
Net assets¥6.67B¥5.94B¥6.08B¥5.83B¥5.09B
Share capital¥4.96B¥4.96B¥4.96B¥4.96B¥4B
Property, plant and equipment¥1.61B¥1.57B¥1.51B¥1.42B¥1.34B
Intangible assets excluding goodwill¥36.3M¥93.6M¥102.5M¥96.8M¥50M
Investment securities———¥150M¥100M
Current assets¥5.95B¥5.21B¥5.34B¥4.82B¥4.18B
Current liabilities¥896.6M¥911.2M¥873.5M¥637.2M¥560.5M
Total liabilities¥931.7M¥946.1M¥908.4M¥688M¥592.7M
Equity attributable to owners of parent¥6.67B¥5.94B¥6.08B¥5.83B¥5.09B
Retained earnings-¥1.08B-¥1.81B-¥1.67B-¥1.92B-¥734.8M
Treasury stock-¥307K-¥307K-¥308K-¥311K-¥311K

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第28期(2025/04/01-2026/03/31)

    ID S100YDBW2026-06-18Open
  • EDINET (FSA Japan)

    有価証券報告書-第27期(2024/04/01-2025/03/31)

    ID S100VZSY2025-06-19Open
  • EDINET (FSA Japan)

    有価証券報告書-第26期(2023/04/01-2024/03/31)

    ID S100TNDE2024-06-19Open
  • EDINET (FSA Japan)

    有価証券報告書-第25期(2022/04/01-2023/03/31)

    ID S100QY5M2023-06-15Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第24期(2021/04/01-2022/03/31)

    ID S100Q2J82023-02-03Open
  • EDINET (FSA Japan)

    有価証券報告書-第23期(令和2年4月1日-令和3年3月31日)

    ID S100LOU72021-06-25Open

Extracted from XBRL: 41 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.